Caffeinated coffee tied to even lower risk than decaffeinated, with no differences seen by brewing method
FRIDAY, Jan. 28, 2022 (HealthDay News) — Increased coffee intake is associated with a lower risk for endometrial cancer (EC), according to a meta-analysis published online Jan. 19 in the Journal of Obstetrics and Gynaecology Research.
Yu Gao, from the Liangxiang Hospital of Beijing, and colleagues conducted a literature review to identify studies evaluating the relationship between coffee drinking and the risk for EC.
Based on 24 included studies (699,234 participants), the researchers found that the pooled relative risk (RR) for endometrial cancer for the highest versus the lowest categories of coffee intake was 0.71. The pooled RRs varied geographically (Europe: RR, 0.74; United States/Canada: RR, 0.71; Japan: RR, 0.40). The inverse association was stronger in caffeinated coffee drinkers (RR, 0.66), individuals with higher body mass index (RR, 0.65), never smokers (RR, 0.68), ever smokers (RR, 0.56), and those who never used hormone replacement therapy (RR, 0.88). There were no significant differences observed based on consumption of filtered or boiled coffee.
“The results may suggest an actual protective link between coffee consumption and anti-endometrial cancer effects,” the authors write. “Further studies with large sample sizes are needed to determine subgroups and to obtain more information regarding the benefits of coffee drinking in relation to the risk of endometrial cancer.”
Obesity Linked to Early-Onset Cancer Risk in Young Adults
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults
Catheter-Based OCT May Help ID Early Endometrial Cancer
Greater Intake of Caffeinated Coffee, Tea May Reduce Dementia Risk
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players
Insomnia Linked to Increased Risk for Stroke, Odds of Admission
Increased Dementia Risk Seen After Transient Ischemic Attack
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia